American Conference Institute’s Life Sciences IP Due Diligence Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers from the leading pharmaceutical companies in the country. This ‘inner circle’ counsels ACI on the impact of emerging trends and current best practices.

Wei Campbell

Director, Patent Counsel
Alnylam Pharmaceuticals (Cambridge, MA)

Hilary Libka

Chief IP Counsel, Associate General Counsel
Memorial Sloan-Kettering Cancer Center

Forrester Liddle

Head of IP and Legal, US R&D
Novo Nordisk (Cambridge, MA)

Kiera Mathey

Assistant General Counsel, Patents
Johnson & Johnson

Sapna Mehtani, Ph.D., J.D.

VP, Head of IP and Legal Affairs
Sonata Therapeutics

Adam Poulin-Kerstien

Vice President, Intellectual Property
Mersana Therapeutics